Limitations of surgery for cancer of the upper gastrointestinal tract;Grenzen der Chirurgie bei Karzinomen des oberen Intestinaltraktes

Chirurg

Volumn 85, Issue 3, 2014, Pages 186-191

  Karakas, E ^a   Oetzmann von Sochaczewski, C ^a   Haist, T ^a   Pauthner, M ^a   Lorenz, D ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Esophagogastric cancers; Limitations; Surgery; Therapy concepts; Tumorstage

Indexed keywords

ADENOCARCINOMA; ADJUVANT THERAPY; ARTICLE; CANCER STAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; TUMOR INVASION;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84897668538     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-013-2598-5     Document Type: Article

References (53)

1. Akutsu Y, Uesato M, Shuto K et al (2013) The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg 257(6):1032-1038.
2. Alderson D (2008) Scottish Intercollegiate Guidelines Network (SIGN) 87-the management of oesophageal and gastric cancer Clin Oncol (R Coll Radiol) 20(7):530-601.
3. Altorki NK, Zhou XK, Stiles B et al (2008) Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248(4):221-226.
4. Alvarez Herrero L, Pouw RE, Vilsteren FG van et al (2010) Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 42(12):1030-1036.
5. Barbour AP, Rizk NP, Gonen M (2007) Adenocarcinoma of the gastroesophageal junction influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1-8.
6. Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143:336-346.
7. Brar SS, Seevaratnam R, Cardoso R et al (2012) Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer 15:100-107.
8. Cense HA, Law S, Wie W (2007) Pharyngolaryngoesophagectomy using the thoracoscopic approach. Surg Endosc 21:879-884.
9. Chan DS, Reid TD, Howell I, Lewis WG (2013) Systematic review and meta-analysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer. Br J Surg 100(4):456-464.
10. Chen Y, Lu Y, Wang Y et al (2012) Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Dis Esophagus. doi:10.1111/j.1442-2050.2012.01440.x (Epub ahead of print).
11. D'Journo XB, Doddoli C, Michelet P et al (2005) Transthoracic esophagectomy for adenocarcinoma of the esophagus: standard versus extended two-field mediastinal lymphadenectomy. Eur J Cardiothorac Surg 27:697-704.
12. Darling G (2009) The role of lymphadenectomy in esophageal cancer. J Surg Oncol 99:189-193.
13. Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol 107:850-862.
14. Fujita H, Sueyoshi S, Tanaka T et al (2005) Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 29:25-31.
15. Gastinger I, Ebeling U, Meyer L et al (2012) Gibt es noch Indikationen für Palliativeingriffe? Chirurg 83:472-479.
16. Gkika E, Gauler T, Eberhardt W et al (2013) Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus doi:10.1111/dote.12146 (Epub ahead of print).
17. Gotoda T, Iwasaki M, Kusano C et al (2010) Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Center criteria. Br J Surg 97:868-871.
18. Groth SS, Virnig BA, Whitson BA et al (2010) Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the surveillance epidemiology and end results database. J Thorac Cardiovasc Surg 139(3):612-620.
19. Grothenhuis BA, Heijl M van, Kate FJW ten et al (2010) Inter-and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinoma. J Clin Pathol 63:978-981.
20. Gutschow C, Schröder W, Wolfgarten E et al (2004) Operation nach Merendino mit Vaguserhaltung beim Frühkarzinom des gastroösophagealen Übergangs. Zentralbl Chir 129:276-281.
21. Hölscher AH, Bollschweiler E, Schröder W et al (2011) Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 254(5):802-808.
22. Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113-123.
23. Japanese Society for Esophageal Diseases (2010) Guidelines for clinical and pathologic studies on carcinoma in the esophagus, 9. Aufl. Kanehara & Co, Ltd., Tokyo.
24. Kähler G (2012) Endoskopische Resektion beim Frühkarzinom des gastroösophagealen Überganges. Chirurg 83:698-701.
25. Kim KH, Lee K-W, Baek SK et al (2011) Survival benefit of gastrectomy-metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer 14:130-138.
26. Leers JM, Demeester SR, Oezcelik A et al (2011) The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma: a retrospective review of esophagectomy specimens. Ann Surg 253:271-278.
27. Manner H, May A, Pech O et al (2008) Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 103(10):2589-2597.
28. Manner H, Pech O, Ell C (2012) Endoscopic therapy in early gastric cancer. Chirurg 83(1):9-15.
29. Mariette C, Piessen G (2012) Oesophageal cancer: how radical should surgery be? Eur J Cancer Surg 38:210-213.
30. Mariette C, Piessen G, Briez N, Triboulet J (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247(2):365-371.
31. Matsubara T, Ueda M, Kokudo N et al (2001) Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 25:279-284.
32. Morita M, Kumashiro R, Hisamatsu Y et al (2011) Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 46(11):1284-1291.
33. Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited tranhiatal resection for adenocarcinoma of the mid/distal esophagus. Five year survival of a randomized clinical trial. Ann Surg 246:992-1001.
34. Ott K, Lordick F, Molls M et al (2009) Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervicl esophagus. Br J Surg 96(3):258-266.
35. Pech O, Ell C (2011) Frühes Ösophaguskarzinom: Pro endoskopische Resektion. Chirurg 82:490-494.
36. Pech O, May A, Gossner L et al (2007) Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 39(1):30-35.
37. Peyre, CG, Hagen JA, DeMeester ST et al (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248(4):549-556.
38. Probst A, Prommer B, Golger D et al (2010) Endoscopic submucosal dissection in gastric cancer neoplasia-experience from a European center. Endoscopy 42(12):1037-1044.
39. Raziee HR, Cardoso R, Seevaratnam R et al (2012) Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival. Gastric Cancer 15:116-124.
40. Rizk NP, Ishwaran H, Rice TW et al (2010) Optimum lymphadenectomy for esophagel cancer. Ann Surg 251:46-50.
41. Moehler M, Al-Batran SE, Andus T et al (2011) S3-Leitlinie "Magenkarzinom"-Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL). German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer". Z Gastroenterol 49:461-531.
42. Sasako M, Sano T, Yamamoto S et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359:453-462.
43. Schuhmacher C, Novotny A, Reim D et al (2011) Lymphadenektomie bei Malignomen des oberen Gastrointestinaltraktes. Chirurg 82:1091-1095.
44. Sepesi B, Watson TJ, Zhou D et al (2010) Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 210:418-427.
45. Shin D, Park S-S (2013) Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer. World J Gastrointest Oncol 5(1):4-11.
46. Sobin LH, Gospodarowicz MK, Wittekind CH (2009) TNM classification of malignant tumors, 7. Aufl. Wiley-Blackwell, USA.
47. Soetikno R, Kaltenbach T, Yeh R et al (2005) Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 23(20):4490-4498.
48. Songun I, Putter H, Meershoek-Klein Kranenbarg E et al (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:439-449.
49. Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 232:733-742.
50. Tong DK, Law S, Kwong DL et al (2011) Current management of cervical esophageal cancer. World J Surg 35(3):600-607.
51. Hagen P van, Hulshof MCCM, Lanschot JJB van et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074-2084.
52. Wani S, Early D, Edmundowicz S et al (2012) Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 10:704-711.
53. Ye T, Sun Y, Zhang Y et al (2013) Three-field or two-field resection for thoracic esophageal cancer: a metaanalysis. Ann Thorac Surg (Epub ahead of print).